Anixa Biosciences (NASDAQ: ANIX) presented data from two clinical-stage immunotherapy programs at the New York Academy of Sciences' Frontiers in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE